12,814 Shares in Ingevity Corporation $NGVT Bought by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd acquired a new stake in Ingevity Corporation (NYSE:NGVT) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 12,814 shares of the company’s stock, valued at approximately $707,000.

Other large investors have also recently made changes to their positions in the company. AQR Capital Management LLC lifted its stake in Ingevity by 10.9% in the first quarter. AQR Capital Management LLC now owns 13,410 shares of the company’s stock worth $518,000 after acquiring an additional 1,323 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Ingevity by 5.2% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,790 shares of the company’s stock valued at $863,000 after buying an additional 1,080 shares during the last quarter. Empowered Funds LLC raised its stake in Ingevity by 12.9% in the first quarter. Empowered Funds LLC now owns 5,181 shares of the company’s stock valued at $205,000 after buying an additional 594 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Ingevity by 311.8% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 600,380 shares of the company’s stock worth $23,769,000 after buying an additional 454,579 shares during the last quarter. Finally, Jane Street Group LLC boosted its position in shares of Ingevity by 306.1% during the 1st quarter. Jane Street Group LLC now owns 88,883 shares of the company’s stock worth $3,519,000 after acquiring an additional 66,995 shares in the last quarter. 91.59% of the stock is currently owned by hedge funds and other institutional investors.

Ingevity Stock Performance

Shares of Ingevity stock opened at $67.08 on Tuesday. The stock has a market capitalization of $2.41 billion, a price-to-earnings ratio of -36.85 and a beta of 1.34. The firm’s fifty day simple moving average is $60.57 and its 200-day simple moving average is $55.75. The company has a debt-to-equity ratio of 8.39, a current ratio of 1.27 and a quick ratio of 0.80. Ingevity Corporation has a 12 month low of $28.49 and a 12 month high of $69.80.

Ingevity (NYSE:NGVT) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $1.52 EPS for the quarter, beating analysts’ consensus estimates of $1.14 by $0.38. Ingevity had a negative net margin of 5.14% and a positive return on equity of 103.69%. The company had revenue of $333.10 million for the quarter, compared to analyst estimates of $360.43 million. During the same period in the previous year, the business posted $1.10 earnings per share. Ingevity’s quarterly revenue was down 3.9% on a year-over-year basis. As a group, equities analysts forecast that Ingevity Corporation will post 4.45 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages have recently weighed in on NGVT. Weiss Ratings reissued a “sell (d-)” rating on shares of Ingevity in a research report on Thursday, January 22nd. Zacks Research upgraded shares of Ingevity to a “hold” rating in a research report on Tuesday, December 16th. BMO Capital Markets upped their target price on shares of Ingevity from $64.00 to $70.00 and gave the company an “outperform” rating in a report on Wednesday, December 10th. Wells Fargo & Company lifted their price target on shares of Ingevity from $60.00 to $65.00 and gave the stock an “equal weight” rating in a research note on Wednesday, January 28th. Finally, Wall Street Zen raised shares of Ingevity from a “buy” rating to a “strong-buy” rating in a research report on Saturday, January 3rd. One equities research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Ingevity has a consensus rating of “Hold” and an average target price of $67.50.

Ingevity Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.